Literature DB >> 19641940

Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood.

Federica Vanoni1, Alberto Bettinelli, Franco Keller, Mario G Bianchetti, Giacomo D Simonetti.   

Abstract

Immunoglobulin (Ig)G antineutrophil cytoplasmic autoantibodies are causally associated with necrotizing vasculitides that are characterized immunopathologically by little or no deposition of immunoreactants, such as Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss angiitis, "renal-limited" vasculitis and a number of drug-induced vasculitides. Clinical routine testing targets the antigens myeloperoxidase and proteinase 3. However, in all of the conditions mentioned, the renal histopathologic findings are indistinguishable. Churg-Strauss angiitis (characterized by necrotizing vasculitis, granulomatous inflammation and tissue eosinophilia), Wegener granulomatosis (characterized by necrotizing vasculitis and granulomatous inflammation) and microscopic polyangiitis (characterized by necrotizing vasculitis) often present with fever, weight loss and a multisystem involvement (ear, nose, throat, lung, eyes, peripheral nerve and heart). Fifty years ago these conditions were very often fatal within 6 months of diagnosis. The introduction of corticosteroids and cyclophosphamide has resulted in a dramatic clinical benefit. Patients who develop treatment-related morbidity can be switched from cyclophosphamide to azathioprine after achieving remission. In patients with less severe disease, methotrexate achieves remission with a success rate similar to that of cyclophosphamide. Plasma exchange, in association with immunosuppression, is likely to be a beneficial therapy for patients with severe kidney disease or pulmonary hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641940     DOI: 10.1007/s00467-009-1253-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  36 in total

Review 1.  Microscopic polyangiitis (microscopic polyarteritis).

Authors:  J C Jennette; D B Thomas; R J Falk
Journal:  Semin Diagn Pathol       Date:  2001-02       Impact factor: 3.464

Review 2.  Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature.

Authors:  R O von Vigier; S A Trummler; R Laux-End; M J Sauvain; A C Truttmann; M G Bianchetti
Journal:  Pediatr Pulmonol       Date:  2000-05

3.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

Review 4.  New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 5.  Wegener's granulomatosis: the current view.

Authors:  Frank Moosig; Peter Lamprecht; Wolfgang L Gross
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

6.  Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases.

Authors:  R Laux-End; H A Gerber; M J Sauvain; M G Bianchetti
Journal:  Acta Paediatr       Date:  1997-04       Impact factor: 2.299

7.  Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children.

Authors:  N Besbas; S Ozen; U Saatci; R Topaloglu; K Tinaztepe; A Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2000-04       Impact factor: 3.714

8.  Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children.

Authors:  Motoshi Hattori; Hideaki Kurayama; Yasushi Koitabashi
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

Review 9.  Drug-induced vasculitis.

Authors:  Allan Wiik
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 10.  Churg-Strauss syndrome: 2005-2008 update.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

View more
  9 in total

Review 1.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

2.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

Review 3.  [Childhood vasculitis].

Authors:  J B Kümmerle-Deschner; J Thomas; S M Benseler
Journal:  Z Rheumatol       Date:  2015-12       Impact factor: 1.372

4.  Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent.

Authors:  Varun Agrawal; Chirag K Vaidya; Jiuming Ye; Jonathan Freeman; Christine McKiernan; Peter R Blier; Chester Andrzejewski; Michael Germain; Gregory L Braden
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

5.  Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis.

Authors:  Daishi Hirano; Tomoaki Ishikawa; Aya Inaba; Mai Sato; Tomohiro Shinozaki; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2019-05-10       Impact factor: 3.714

Review 6.  Vasculitis: do we know more to classify better?

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

Review 7.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

Review 8.  Cutaneous Manifestations of Small-Vessel Leukocytoclastic Vasculitides in Childhood.

Authors:  Sebastiano A G Lava; Gregorio P Milani; Emilio F Fossali; Giacomo D Simonetti; Carlo Agostoni; Mario G Bianchetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

9.  Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.

Authors:  Paul Brogan; Rae S M Yeung; Gavin Cleary; Satyapal Rangaraj; Ozgur Kasapcopur; Aimee O Hersh; Suzanne Li; Dusan Paripovic; Kenneth Schikler; Andrew Zeft; Claudia Bracaglia; Despina Eleftheriou; Pooneh Pordeli; Simone Melega; Candice Jamois; Jacques Gaudreault; Margaret Michalska; Paul Brunetta; Jennifer C Cooper; Patricia B Lehane
Journal:  Arthritis Rheumatol       Date:  2021-12-05       Impact factor: 15.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.